Current applications of nanoparticles in infectious diseases

Journal of Controlled Release

Volumn 224, Issue , 2016, Pages 86-102

  Zazo, Hinojal ^a,b   Colino, Clara I ^a,b   Lanao, José M ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

Author keywords

Antimicrobial; Drug delivery; Infections; Nanoparticles

Indexed keywords

ANTIMICROBIAL AGENTS; CLINICAL RESEARCH; CONTROLLED DRUG DELIVERY; DISEASES; DRUG DELIVERY; DRUG INTERACTIONS; NANOPARTICLES; VIRUSES;

ADVERSE SIDE EFFECTS; ANTIMICROBIAL; ANTIMICROBIAL RESISTANCES; DIFFERENT MECHANISMS; INFECTIONS; MULTIDRUG RESISTANTS; NANOPARTICLE SYSTEMS; THERAPEUTIC LEVELS;

TARGETED DRUG DELIVERY;

ALUMINUM NANOPARTICLE; ANTIINFECTIVE AGENT; COPPER NANOPARTICLE; GOLD NANOPARTICLE; INORGANIC NANOPARTICLE; IRON NANOPARTICLE; LIGAND; LIPOSOME; NAKED NANOPARTICLE; NANOCARRIER; NANOPARTICLE; ORGANIC NANOPARTICLE; PALLADIUM NANOPARTICLE; PLATINUM NANOPARTICLE; POLYMERIC MICELLE; POLYMERIC NANOPARTICLE; SILVER NANOPARTICLE; SOLID LIPID NANOPARTICLE; TITANIUM NANOPARTICLE; UNCLASSIFIED DRUG; VACCINE; ZINC NANOPARTICLE;

BIOFILM; BONE INFECTION; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DRUG RELEASE; HELICOBACTER INFECTION; HUMAN; INFECTION; LIPOSOMAL DELIVERY; LUNG INFECTION; MEDICAL DEVICE; MICELLE; NANOMEDICINE; NANOPHARMACEUTICS; NANOTOXICOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; THERANOSTIC NANOMEDICINE; ANIMAL; DRUG DELIVERY SYSTEM;

ANIMALS; ANTI-INFECTIVE AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; INFECTION; NANOPARTICLES;

EID: 84954287832     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.01.008     Document Type: Review

References (282)

1. U.S. Department of Health and Human Services, and Food and Drug Administration, Guidance for Industry Considering Whether an FDA-regulated Product Involves the Application of Nanotechnology 2014
2. M. Vert, Y. Doi, K. Hellwich, M. Hess, P. Hodge, P. Kubisa, M. Rinaudo, and F. Schué Terminology for biorelated polymers and applications (IUPAC recommendations) Pure Appl. Chem. 84 2012 2012 377 410
3. S. Bamrungsap, Z. Zhao, T. Chen, L. Wang, C. Li, T. Fu, and W. Tan Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system Nanomedicine (London) 7 2012 1253 1271
4. K. James, J. Highsmith, and P. Evers Nanotechnology market - nanotechnology markets in healthcare & medicine Drug Dev. Deliv. 11 12 2014 43 45
5. P.F. Bonventre, and G. Gregoriandis Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes Antimicrob. Agents Chemother. 13 1978 1049 1051
6. I.P. Kaur, and S. Kakkar Nanotherapy for posterior eye diseases J. Control. Release 193 2014 100 112
7. M.A. Lauzon, A. Daviau, B. Marcos, and N. Faucheux Nanoparticle-mediated growth factor delivery systems: a new way to treat Alzheimer's disease J. Control. Release 206 2015 187 205
8. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
9. J. Panyam, and V. Labhasetwar Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles Mol. Pharm. 1 2004 77 84
10. P. Sendi, and R.A. Proctor Staphylococcus aureus as an intracellular pathogen: the role of small colony variants Trends Microbiol. 17 2009 54 58
11. World Health Organization (WHO) Anti-Microbial Resistance Global Report on Surveillance. 2014 Summary 2014 WHO Press
12. R. Singh, M.S. Smitha, and S.P. Singh The role of nanotechnology in combating multi-drug resistant bacteria J. Nanosci. Nanotechnol. 14 2014 4745 4756
13. M.N. Alekshun, and S.B. Levy Molecular mechanisms of antibacterial multidrug resistance Cell 128 2007 1037 1050
14. B. Katz, and K. Waites Emerging intracellular bacterial infections Clin. Lab. Med. 24 2004 627 649
15. E. Briones, C.I. Colino, and J.M. Lanao Delivery systems to increase the selectivity of antibiotics in phagocytic cells J. Control. Release 125 2008 210 227
16. A. Mukhopadhyay, and S.K. Basu Intracellular delivery of drugs to macrophages Adv. Biochem. Eng. Biotechnol. 84 2003 183 209
17. A.L. Armstead, and B. Li Nanomedicine as an emerging approach against intracellular pathogens Int. J. Nanomedicine 6 2011 3281 3293
18. R. Kalluru, F. Fenaroli, D. Westmoreland, L. Ulanova, A. Maleki, N. Roos, M. Paulsen Madsen, G. Koster, W. Egge-Jacobsen, S. Wilson, H. Roberg-Larsen, G.K. Khuller, A. Singh, B. Nystrom, and G. Griffiths Poly(lactide-co-glycolide)-rifampicin nanoparticles efficiently clear Mycobacterium bovis BCG infection in macrophages and remain membrane-bound in phago-lysosomes J. Cell Sci. 126 2013 3043 3054
19. 3H)ampicillin-loaded nanoparticles J. Antimicrob. Chemother. 37 1996 105 115
20. R. Parboosing, G.E. Maguire, P. Govender, and H.G. Kruger Nanotechnology and the treatment of HIV infection Viruses 4 2012 488 520
21. A.G. Tkachenko, H. Xie, D. Coleman, W. Glomm, J. Ryan, M.F. Anderson, S. Franzen, and D.L. Feldheim Multifunctional gold nanoparticle-peptide complexes for nuclear targeting J. Am. Chem. Soc. 125 2003 4700 4701
22. J.K. Vasir, and V. Labhasetwar Biodegradable nanoparticles for cytosolic delivery of therapeutics Adv. Drug Deliv. Rev. 59 2007 718 728
23. A. Shibata, E. McMullen, A. Pham, M. Belshan, B. Sanford, Y. Zhou, M. Goede, A.A. Date, and C.J. Destache Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment AIDS Res. Hum. Retrovir. 29 2013 746 754
24. R.R. Arvizo, S. Bhattacharyya, R.A. Kudgus, K. Giri, R. Bhattacharya, and P. Mukherjee Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future Chem. Soc. Rev. 41 2012 2943 2970
25. V.V. Mody, R. Siwale, A. Singh, and H.R. Mody Introduction to metallic nanoparticles J. Pharm. Bioallied Sci. 2 2010 282 289
26. G. Zhao, Y. Huang, G. Li, S. Li, Y. Zhou, Y. Lei, X. Chen, K. Yang, Y. Chen, and K. Yang Subcellular distribution and genotoxicity of silica nanoparticles in human bronchial epithelial cells Zhongguo Fei Ai Za Zhi. 16 2013 117 124
27. J. Rai, G.K. Randhawa, and M. Kaur Recent advances in antibacterial drugs Int. J. Appl. Basic Med. Res. 3 2013 3 10
28. C.H. Chang, Y.H. Lin, C.L. Yeh, Y.C. Chen, S.F. Chiou, Y.M. Hsu, Y.S. Chen, and C.C. Wang Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori Biomacromolecules 11 2010 133 142
29. D. Lembo, and R. Cavalli Nanoparticulate delivery systems for antiviral drugs Antivir. Chem. Chemother. 21 2010 53 70
30. J.D. Kingsley, H. Dou, J. Morehead, B. Rabinow, H.E. Gendelman, and C.J. Destache Nanotechnology: a focus on nanoparticles as a drug delivery system J. NeuroImmune Pharmacol. 1 2006 340 350
31. C.J. Destache, T. Belgum, M. Goede, A. Shibata, and M.A. Belshan Antiretroviral release from poly(dl-lactide-co-glycolide) nanoparticles in mice J. Antimicrob. Chemother. 65 2010 2183 2187
32. J.P. Freeling, J. Koehn, C. Shu, J. Sun, and R.J. Ho Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood AIDS 28 2014 2625 2627
33. C.A. Schutz, L. Juillerat-Jeanneret, H. Mueller, I. Lynch, M. Riediker, and NanoImpactNet Consortium Therapeutic nanoparticles in clinics and under clinical evaluation Nanomedicine (London) 8 2013 449 467
34. K. Forier, K. Raemdonck, S.C. De Smedt, J. Demeester, T. Coenye, and K. Braeckmans Lipid and polymer nanoparticles for drug delivery to bacterial biofilms J. Control. Release 190 2014 607 623
35. S. Xie, Y. Tao, Y. Pan, W. Qu, G. Cheng, L. Huang, D. Chen, X. Wang, Z. Liu, and Z. Yuan Biodegradable nanoparticles for intracellular delivery of antimicrobial agents J. Control. Release 187 2014 101 117
36. S. Doktorovova, E.B. Souto, and A.M. Silva Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data Eur. J. Pharm. Biopharm. 87 2014 1 18
37. R. Mehendale, M. Joshi, and V.B. Patravale Nanomedicines for treatment of viral diseases Crit. Rev. Ther. Drug Carrier Syst. 30 2013 1 49
38. P.A. Patel, and V.B. Patravale AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration J. Biomed. Nanotechnol. 7 2011 632 639
39. U. Gupta, and N.K. Jain Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting Adv. Drug Deliv. Rev. 62 2010 478 490
40. B. Semete, L. Booysen, Y. Lemmer, L. Kalombo, L. Katata, J. Verschoor, and H.S. Swai In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems Nanomedicine 6 2010 662 671
41. M. Kolter, M. Ott, C. Hauer, I. Reimold, and G. Fricker Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo J. Control. Release 197 2015 165 179
42. J.E. Vela-Ramirez, J.T. Goodman, P.M. Boggiatto, R. Roychoudhury, N.L. Pohl, J.M. Hostetter, M.J. Wannemuehler, and B. Narasimhan Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles AAPS J. 17 2015 256 267
43. J.L. Italia, M.M. Yahya, D. Singh, and M.N. Ravi Kumar Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone Pharm. Res. 26 2009 1324 1331
44. K.A. Ghaffar, A.K. Giddam, M. Zaman, M. Skwarczynski, and I. Toth Liposomes as nanovaccine delivery systems Curr. Top. Med. Chem. 14 2014 1194 1208
45. S. Hansen, and C.M. Lehr Nanoparticles for transcutaneous vaccination Microb. Biotechnol. 5 2012 156 167
46. G. Bozzuto, and A. Molinari Liposomes as nanomedical devices Int. J. Nanomedicine 10 2015 975 999
47. T. Borel, and C.M. Sabliov Nanodelivery of bioactive components for food applications: types of delivery systems, properties, and their effect on ADME profiles and toxicity of nanoparticles Annu. Rev. Food Sci. Technol. 5 2014 197 213
48. I.C. Goncalves, P.C. Henriques, C.L. Seabra, and M.C. Martins The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection Expert Rev. Anti-Infect. Ther. 12 2014 981 992
49. J.L. Italia, A. Sharp, K.C. Carter, P. Warn, and M.N. Kumar Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone PLoS One 6 2011 e25744
50. S.M. Abdelghany, D.J. Quinn, R.J. Ingram, B.F. Gilmore, R.F. Donnelly, C.C. Taggart, and C.J. Scott Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection Int. J. Nanomedicine 7 2012 4053 4063
51. R.A. Jain The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 2000 2475 2490
52. D. Mishra, N. Jain, V. Rajoriya, and A.K. Jain Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine J. Pharm. Pharmacol. 66 2014 1082 1093
53. B.J. Edagwa, D. Guo, P. Puligujja, H. Chen, J. McMillan, X. Liu, H.E. Gendelman, and P. Narayanasamy Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes FASEB J. 28 2014 5071 5082
54. P.K. Gupta, A.K. Jaiswal, S. Asthana, A. Verma, V. Kumar, P. Shukla, P. Dwivedi, A. Dube, and P.R. Mishra Self-assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis Pharm. Res. 32 2015 1727 1740
55. H.K. Ibrahim, I.S. El-Leithy, and A.A. Makky Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy Mol. Pharm. 7 2010 576 585
56. A.O. Kamel, G.A. Awad, A.S. Geneidi, and N.D. Mortada Preparation of intravenous stealthy acyclovir nanoparticles with increased mean residence time AAPS PharmSciTech 10 2009 1427 1436
57. G. Kumar, S. Sharma, N. Shafiq, P. Pandhi, G.K. Khuller, and S. Malhotra Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis Drug Deliv. 18 2011 65 73
58. D.P. Gnanadhas, M. Ben Thomas, M. Elango, A.M. Raichur, and D. Chakravortty Chitosan-dextran sulphate nanocapsule drug delivery system as an effective therapeutic against intraphagosomal pathogen Salmonella J. Antimicrob. Chemother. 68 2013 2576 2586
59. P. Bawa, V. Pillay, Y.E. Choonara, and L.C. du Toit Stimuli-responsive polymers and their applications in drug delivery Biomed. Mater. 4 2009 022001
60. M. Kaur, T. Garg, G. Rath, and A.K. Goyal Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis Crit. Rev. Ther. Drug Carrier Syst. 31 2014 49 88
61. M. Yokoyama Polymeric micelles as drug carriers: their lights and shadows J. Drug Target. 22 2014 576 583
62. A. Badiee, V. Heravi Shargh, A. Khamesipour, and M.R. Jaafari Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends Vaccine 31 2013 735 749
63. Y. Jin, L. Tong, P. Ai, M. Li, and X. Hou Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN) Int. J. Pharm. 309 2006 199 207
64. M.V. Vadakkan, K. Annapoorna, K.C. Sivakumar, S. Mundayoor, and G.S. Kumar Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage Int. J. Nanomedicine 8 2013 2871 2885
65. U. Bhosale, D.V. Kusum, and N. Jain Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovir J. Young Pharm. 3 2011 275 283
66. S.S. Dodiya, S.S. Chavhan, K.K. Sawant, and A.G. Korde Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies J. Microencapsul. 28 2011 515 527
67. M. Kumar, V. Kakkar, A.K. Mishra, K. Chuttani, and I.P. Kaur Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood Int. J. Pharm. 461 2014 223 233
68. R. Pandey, S. Sharma, and G.K. Khuller Oral solid lipid nanoparticle-based antitubercular chemotherapy Tuberc. (Edinb) 85 2005 415 420
69. S.D. Mahajan, R. Aalinkeel, W.C. Law, J.L. Reynolds, B.B. Nair, D.E. Sykes, K.T. Yong, I. Roy, P.N. Prasad, and S.A. Schwartz Anti-HIV-1 nanotherapeutics: promises and challenges for the future Int. J. Nanomedicine 7 2012 5301 5314
70. J. Turkevich Colloidal gold. Part I Gold Bull. 18 3 1985 86 91
71. P. Ghosh, G. Han, M. De, C.K. Kim, and V.M. Rotello Gold nanoparticles in delivery applications Adv. Drug Deliv. Rev. 60 2008 1307 1315
72. G. Frens Controlled nucleation for the regulation of particle size in monodisperse gold suspensions Nat. Phys. Sci. 241 1973 20 21 22
73. D.P. Gnanadhas, M. Ben Thomas, R. Thomas, A.M. Raichur, and D. Chakravortty Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo Antimicrob. Agents Chemother. 57 2013 4945 4955
74. S. Iravani Bacteria in nanoparticle synthesis: current status and future prospects Hindawi 2014 1 18
75. N.I. Hulkoti, and T.C. Taranath Biosynthesis of nanoparticles using microbes - a review Colloids Surf. B: Biointerfaces 121 2014 474 483
76. Y. Zhao, and X. Jiang Multiple strategies to activate gold nanoparticles as antibiotics Nanoscale 5 2013 8340 8350
77. N. Bertrand, and J.C. Leroux The journey of a drug-carrier in the body: an anatomo-physiological perspective J. Control. Release 161 2012 152 163
78. L. Ge, Q. Li, M. Wang, J. Ouyang, X. Li, and M.M. Xing Nanosilver particles in medical applications: synthesis, performance, and toxicity Int. J. Nanomedicine 9 2014 2399 2407
79. J. Sengupta, S. Ghosh, P. Datta, A. Gomes, and A. Gomes Physiologically important metal nanoparticles and their toxicity J. Nanosci. Nanotechnol. 14 2014 990 1006
80. Z. He, J. Liu, and L. Du The unexpected effect of PEGylated gold nanoparticles on the primary function of erythrocytes Nanoscale 6 2014 9017 9024
81. L. Wei, J. Lu, H. Xu, A. Patel, Z.S. Chen, and G. Chen Silver nanoparticles: synthesis, properties, and therapeutic applications Drug Discov. Today 20 2015 595 601
82. S. Ahlberg, A. Antonopulos, J. Diendorf, R. Dringen, M. Epple, R. Flock, W. Goedecke, C. Graf, N. Haberl, J. Helmlinger, F. Herzog, F. Heuer, S. Hirn, C. Johannes, S. Kittler, M. Koller, K. Korn, W.G. Kreyling, F. Krombach, J. Lademann, K. Loza, E.M. Luther, M. Malissek, M.C. Meinke, D. Nordmeyer, A. Pailliart, J. Raabe, F. Rancan, B. Rothen-Rutishauser, E. Ruhl, C. Schleh, A. Seibel, C. Sengstock, L. Treuel, A. Vogt, K. Weber, and R. Zellner PVP-coated, negatively charged silver nanoparticles: a multi-center study of their physicochemical characteristics, cell culture and in vivo experiments Beilstein J. Nanotechnol. 5 2014 1944 1965
83. A.M. Schrand, M.F. Rahman, S.M. Hussain, J.J. Schlager, D.A. Smith, and A.F. Syed Metal-based nanoparticles and their toxicity assessment Wiley Interdiscip. Rev. Nanomed Nanobiotechnol. 2 2010 544 568
84. R. Duncan, and R. Gaspar Nanomedicine(s) under the microscope Mol. Pharm. 8 2011 2101 2141
85. L. Ding, Z. Liu, M.O. Aggrey, C. Li, J. Chen, and L. Tong Nanotoxicity: the toxicity research progress of metal and metal-containing nanoparticles Mini-Rev. Med. Chem. 15 2015 529 542
86. Y. Arai, T. Miyayama, and S. Hirano Difference in the toxicity mechanism between ion and nanoparticle forms of silver in the mouse lung and in macrophages Toxicology 328 2015 84 92
87. K. Pfurtscheller, T. Petnehazy, W. Goessler, V. Bubalo, L.P. Kamolz, and M. Trop Transdermal uptake and organ distribution of silver from two different wound dressings in rats after a burn trauma Wound Repair Regen. 22 2014 654 659
88. C.M. Goodman, C.D. McCusker, T. Yilmaz, and V.M. Rotello Toxicity of gold nanoparticles functionalized with cationic and anionic side chains Bioconjug. Chem. 15 2004 897 900
89. G.P. Devi, K.B. Ahmed, M.K. Varsha, B.S. Shrijha, K.K. Lal, V. Anbazhagan, and R. Thiagarajan Sulfidation of silver nanoparticle reduces its toxicity in zebrafish Aquat. Toxicol. 158 2015 149 156
90. C. Levard, E.M. Hotze, B.P. Colman, A.L. Dale, L. Truong, X.Y. Yang, A.J. Bone, G.E. Brown Jr., R.L. Tanguay, R.T. Di Giulio, E.S. Bernhardt, J.N. Meyer, M.R. Wiesner, and G.V. Lowry Sulfidation of silver nanoparticles: natural antidote to their toxicity Environ. Sci. Technol. 47 2013 13440 13448
91. A.N. Grace, and K. Pandian Antibacterial efficacy of aminoglycosidic antibiotics protected gold nanoparticles - a brief study Colloids Surf. A 297 2007 63 70
92. A.M. Paul, Y. Shi, D. Acharya, J.R. Douglas, A. Cooley, J.F. Anderson, F. Huang, and F. Bai Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro J. Gen. Virol. 95 2014 1712 1722
93. L. Xu, Y. Liu, Z. Chen, W. Li, Y. Liu, L. Wang, Y. Liu, X. Wu, Y. Ji, Y. Zhao, L. Ma, Y. Shao, and C. Chen Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment Nano Lett. 12 2012 2003 2012
94. F. Furno, K.S. Morley, B. Wong, B.L. Sharp, P.L. Arnold, S.M. Howdle, R. Bayston, P.D. Brown, P.D. Winship, and H.J. Reid Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J. Antimicrob. Chemother. 54 2004 1019 1024
95. S. Giri, B.G. Trewyn, and V.S. Lin Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems Nanomedicine (London) 2 2007 99 111
96. M.N. Seleem, P. Munusamy, A. Ranjan, H. Alqublan, G. Pickrell, and N. Sriranganathan Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens Antimicrob. Agents Chemother. 53 2009 4270 4274
97. M.S. Usman, M.E. El Zowalaty, K. Shameli, N. Zainuddin, M. Salama, and N.A. Ibrahim Synthesis, characterization, and antimicrobial properties of copper nanoparticles Int. J. Nanomedicine 8 2013 4467 4479
98. A.J. Huh, and Y.J. Kwon "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era J. Control. Release 156 2011 128 145
99. S.D. Mahajan, I. Roy, G. Xu, K.T. Yong, H. Ding, R. Aalinkeel, J. Reynolds, D. Sykes, B.B. Nair, E.Y. Lin, P.N. Prasad, and S.A. Schwartz Enhancing the delivery of anti-retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles Curr. HIV Res. 8 2010 396 404
100. J. Peng, H.L. Chen, X.B. Zhu, G.F. Yang, Z.L. Zhang, Z.Q. Tian, and D.W. Pang Detection of Epstein-Barr virus infection in gastric carcinomas using quantum dot-based fluorescence in-situ hybridization J. Nanosci. Nanotechnol. 11 2011 9725 9730
101. S. Maleki Dizaj, A. Mennati, S. Jafari, K. Khezri, and K. Adibkia Antimicrobial activity of carbon-based nanoparticles Adv. Pharm. Bull. 5 2015 19 23
102. J. Pruthi, N.K. Mehra, and N.K. Jain Macrophages targeting of amphotericin B through mannosylated multiwalled carbon nanotubes J. Drug Target. 20 2012 593 604
103. N. Saikia, S. Rajkhowa, and R.C. Deka Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein J. Comput. Aided Mol. Des. 27 2013 257 276
104. R. Cavalli, A. Bisazza, and D. Lembo Micro- and nanobubbles: a versatile non-viral platform for gene delivery Int. J. Pharm. 456 2013 437 445
105. R. Cavalli, M. Argenziano, E. Vigna, P. Giustetto, E. Torres, S. Aime, and E. Terreno Preparation and in vitro characterization of chitosan nanobubbles as theranostic agents Colloids Surf. B: Biointerfaces 129 2015 39 46
106. E.Y. Lukianova-Hleb, A. Belyanin, S. Kashinath, X. Wu, and D.O. Lapotko Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells Biomaterials 33 2012 1821 1826
107. T.L. Pan, P.W. Wang, S.A. Al-Suwayeh, Y.J. Huang, and J.Y. Fang Toxicological effects of cationic nanobubbles on the liver and kidneys: biomarkers for predicting the risk Food Chem. Toxicol. 50 2012 3892 3901
108. T.L. Hwang, C.L. Fang, S.A. Al-Suwayeh, L.J. Yang, and J.Y. Fang Activated human neutrophil response to perfluorocarbon nanobubbles: oxygen-dependent and -independent cytotoxic responses Toxicol. Lett. 203 2011 172 180
109. C.J. Cheng, G.T. Tietjen, J.K. Saucier-Sawyer, and W.M. Saltzman A holistic approach to targeting disease with polymeric nanoparticles Nat. Rev. Drug Discov. 14 2015 239 247
110. M. Alhariri, A. Azghani, and A. Omri Liposomal antibiotics for the treatment of infectious diseases Expert Opin. Drug Deliv. 10 2013 1515 1532
111. F. Andrade, D. Rafael, M. Videira, D. Ferreira, A. Sosnik, and B. Sarmento Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases Adv. Drug Deliv. Rev. 65 2013 1816 1827
112. S. Tiwari, S.K. Verma, G.P. Agrawal, and S.P. Vyas Viral protein complexed liposomes for intranasal delivery of hepatitis B surface antigen Int. J. Pharm. 413 2011 211 219
113. E. van Riet, A. Ainai, T. Suzuki, G. Kersten, and H. Hasegawa Combatting infectious diseases; nanotechnology as a platform for rational vaccine design Adv. Drug Deliv. Rev. 74 2014 28 34
114. S. Gunaseelan, K. Gunaseelan, M. Deshmukh, X. Zhang, and P.J. Sinko Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs Adv. Drug Deliv. Rev. 62 2010 518 531
115. M. Abdulkarim, N. Agullo, B. Cattoz, P. Griffiths, A. Bernkop-Schnurch, S.G. Borros, and M. Gumbleton Nanoparticle diffusion within intestinal mucus: three-dimensional response analysis dissecting the impact of particle surface charge, size and heterogeneity across polyelectrolyte, pegylated and viral particles Eur. J. Pharm. Biopharm. 97 2015 230 238
116. I.A. Wani, S. Khatoon, A. Ganguly, J. Ahmed, T. Ahmad, and N. Manzoor Structural characterization and antimicrobial properties of silver nanoparticles prepared by inverse microemulsion method Colloids Surf. B: Biointerfaces 101 2013 243 250
117. I.A. Wani, T. Ahmad, and N. Manzoor Size and shape dependant antifungal activity of gold nanoparticles: a case study of Candida Colloids Surf. B: Biointerfaces 101 2013 162 170
118. G. Mohammadi, A. Nokhodchi, M. Barzegar-Jalali, F. Lotfipour, K. Adibkia, N. Ehyaei, and H. Valizadeh Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system Colloids Surf. B: Biointerfaces 88 2011 39 44
119. S. Hirn, M. Semmler-Behnke, C. Schleh, A. Wenk, J. Lipka, M. Schaffler, S. Takenaka, W. Moller, G. Schmid, U. Simon, and W.G. Kreyling Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration Eur. J. Pharm. Biopharm. 77 2011 407 416
120. F. Chellat, Y. Merhi, A. Moreau, and L. Yahia Therapeutic potential of nanoparticulate systems for macrophage targeting Biomaterials 26 2005 7260 7275
121. R. Gossmann, E. Fahrlander, M. Hummel, D. Mulac, J. Brockmeyer, and K. Langer Comparative examination of adsorption of serum proteins on HSA- and PLGA-based nanoparticles using SDS-PAGE and LC-MS Eur. J. Pharm. Biopharm. 93 2015 80 87
122. R.Y. Pelgrift, and A.J. Friedman Nanotechnology as a therapeutic tool to combat microbial resistance Adv. Drug Deliv. Rev. 65 2013 1803 1815
123. S. Lorenz, C.P. Hauser, B. Autenrieth, C.K. Weiss, K. Landfester, and V. Mailander The softer and more hydrophobic the better: influence of the side chain of polymethacrylate nanoparticles for cellular uptake Macromol. Biosci. 10 2010 1034 1042
124. G.K. Saraogi, B. Sharma, B. Joshi, P. Gupta, U.D. Gupta, N.K. Jain, and G.P. Agrawal Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis J. Drug Target. 19 2011 219 227
125. V. Gajbhiye, N. Ganesh, J. Barve, and N.K. Jain Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers Eur. J. Pharm. Sci. 48 2013 668 679
126. A.N. Endsley, and R.J. Ho Enhanced anti-HIV efficacy of indinavir after inclusion in CD4-targeted lipid nanoparticles J. Acquir. Immune Defic. Syndr. 61 2012 417 424
127. N. Marasini, M. Skwarczynski, and I. Toth Oral delivery of nanoparticle-based vaccines Expert Rev. Vaccines 13 2014 1361 1376
128. S. Kawakami, and M. Hashida Glycosylation-mediated targeting of carriers J. Control. Release 190 2014 542 555
129. S.M. Farkhani, A. Valizadeh, H. Karami, S. Mohammadi, N. Sohrabi, and F. Badrzadeh Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules Peptides 57 2014 78 94
130. J.S. Bahnsen, H. Franzyk, A. Sandberg-Schaal, and H.M. Nielsen Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure Biochim. Biophys. Acta 1828 2013 223 232
131. K.J. Longmuir, R.T. Robertson, S.M. Haynes, J.L. Baratta, and A.J. Waring Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence Pharm. Res. 23 2006 759 769
132. J. Kreuter Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv. Drug Deliv. Rev. 71 2014 2 14
133. R. Lobenberg, L. Araujo, H. von Briesen, E. Rodgers, and J. Kreuter Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats J. Control. Release 50 1998 21 30
134. N. Xu, J. Gu, Y. Zhu, H. Wen, Q. Ren, and J. Chen Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice Int. J. Nanomedicine 6 2011 905 913
135. V. Mishra, S. Mahor, A. Rawat, P.N. Gupta, P. Dubey, K. Khatri, and S.P. Vyas Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles J. Drug Target. 14 2006 45 53
136. Y. Gupta, A. Jain, and S.K. Jain Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain J. Pharm. Pharmacol. 59 2007 935 940
137. Y.C. Kuo, and H.F. Ko Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles Biomaterials 34 2013 4818 4830
138. N. Oh, and J.H. Park Surface chemistry of gold nanoparticles mediates their exocytosis in macrophages ACS Nano 8 2014 6232 6241
139. P. Laverman, M.G. Carstens, O.C. Boerman, E.T. Dams, W.J. Oyen, N. van Rooijen, F.H. Corstens, and G. Storm Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection J. Pharmacol. Exp. Ther. 298 2001 607 612
140. J.S. Park, T.H. Han, K.Y. Lee, S.S. Han, J.J. Hwang, D.H. Moon, S.Y. Kim, and Y.W. Cho N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release J. Control. Release 115 2006 37 45
141. T. Zhang, T.F. Sturgis, and B.B. Youan pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission Eur. J. Pharm. Biopharm. 79 2011 526 536
142. A. Dembri, M.J. Montisci, J.C. Gantier, H. Chacun, and G. Ponchel Targeting of 3′-azido 3′-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues Pharm. Res. 18 2001 467 473
143. K. Hadinoto, and W.S. Cheow Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa Colloids Surf. B: Biointerfaces 116 2014 772 785
144. X. Hua, S. Tan, H.M. Bandara, Y. Fu, S. Liu, and H.D. Smyth Externally controlled triggered-release of drug from PLGA micro and nanoparticles PLoS One 9 2014 e114271
145. M. Yin, Z. Li, E. Ju, Z. Wang, K. Dong, J. Ren, and X. Qu Multifunctional upconverting nanoparticles for near-infrared triggered and synergistic antibacterial resistance therapy Chem. Commun. (Camb) 50 2014 10488 10490
146. E. Addae, X. Dong, E. McCoy, C. Yang, W. Chen, and L. Yang Investigation of antimicrobial activity of photothermal therapeutic gold/copper sulfide core/shell nanoparticles to bacterial spores and cells J. Biol. Eng. 8 2014 11
147. L. Rastogi, A.J. Kora, Highly stable, protein capped gold nanoparticles as effective drug delivery vehicles for amino-glycosidic antibiotics, Mater. Sci. Eng. C. Mater. Biol. Appl. 32 (2012) 1571-1577.
148. M. Harshiny, M. Matheswaran, G. Arthanareeswaran, S. Kumaran, and S. Rajasree Enhancement of antibacterial properties of silver nanoparticles-ceftriaxone conjugate through Mukia maderaspatana leaf extract mediated synthesis Ecotoxicol. Environ. Saf. 121 2015 135 141
149. A.M. Allahverdiyev, K.V. Kon, E.S. Abamor, M. Bagirova, and M. Rafailovich Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents Expert Rev. Anti-Infect. Ther. 9 2011 1035 1052
150. N.P. Aditya, P.G. Vathsala, V. Vieira, R.S. Murthy, and E.B. Souto Advances in nanomedicines for malaria treatment Adv. Colloid Interf. Sci. 201-202 2013 1 17
151. A.H. Alomrani, G.A. Shazly, A.A. Amara, and M.M. Badran Itraconazole-hydroxypropyl-beta-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model Colloids Surf. B: Biointerfaces 121 2014 74 81
152. J. Pandit, M. Garg, and N.K. Jain Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection J. Liposome Res. 24 2014 163 169
153. M. Ali, M. Afzal, S.M. Bhattacharya, F.J. Ahmad, and A.K. Dinda Nanopharmaceuticals to target antifilarials: a comprehensive review Expert Opin. Drug Deliv. 10 2013 665 678
154. T.J. Spitzenberger, D. Heilman, C. Diekmann, E.V. Batrakova, A.V. Kabanov, H.E. Gendelman, W.F. Elmquist, and Y. Persidsky Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis J. Cereb. Blood Flow Metab. 27 2007 1033 1042
155. D.A. Chiappetta, C. Hocht, J.A. Opezzo, and A. Sosnik Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV Nanomedicine (London) 8 2013 223 237
156. A.C. Amaral, A.L. Bocca, A.M. Ribeiro, J. Nunes, D.L. Peixoto, A.R. Simioni, F.L. Primo, Z.G. Lacava, R. Bentes, R. Titze-de-Almeida, A.C. Tedesco, P.C. Morais, and M.S. Felipe Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis J. Antimicrob. Chemother. 63 2009 526 533
157. T.G. Ribeiro, J.R. Franca, L.L. Fuscaldi, M.L. Santos, M.C. Duarte, P.S. Lage, V.T. Martins, L.E. Costa, S.O. Fernandes, V.N. Cardoso, R.O. Castilho, M. Soto, C.A. Tavares, A.A. Faraco, E.A. Coelho, and M.A. Chavez-Fumagalli An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis Int. J. Nanomedicine 9 2014 5341 5353
158. M. Owais, G.C. Varshney, A. Choudhury, S. Chandra, and C.M. Gupta Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice Antimicrob. Agents Chemother. 39 1995 180 184
159. M.M. Mehanna, S.M. Mohyeldin, and N.A. Elgindy Respirable nanocarriers as a promising strategy for antitubercular drug delivery J. Control. Release 187 2014 183 197
160. Y.S. Chhonker, Y.D. Prasad, H. Chandasana, A. Vishvkarma, K. Mitra, P.K. Shukla, and R.S. Bhatta Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application Int. J. Biol. Macromol. 72 2015 1451 1458
161. A.N. Brown, K. Smith, T.A. Samuels, J. Lu, S.O. Obare, and M.E. Scott Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus Appl. Environ. Microbiol. 78 2012 2768 2774
162. N. Shaik, G. Pan, and W.F. Elmquist Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors J. Pharm. Sci. 97 2008 5421 5433
163. S.P. Chakraborty, S.K. Sahu, P. Pramanik, and S. Roy In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus Int. J. Pharm. 436 2012 659 676
164. C. Longhi, J.P. Santos, A.T. Morey, P.D. Marcato, N. Duran, P. Pinge-Filho, G. Nakazato, S.F. Yamada-Ogatta, and L.M. Yamauchi Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans Med. Mycol. 19 2015 (Epub)
165. L. Wang, Y.P. Chen, K.P. Miller, B.M. Cash, S. Jones, S. Glenn, B.C. Benicewicz, and A.W. Decho Functionalised nanoparticles complexed with antibiotic efficiently kill MRSA and other bacteria Chem. Commun. (Camb) 50 2014 12030 12033
166. S.H. Hussein-Al-Ali, M.E. El Zowalaty, M.Z. Hussein, M. Ismail, and T.J. Webster Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic Int. J. Nanomedicine 9 2014 549 557
167. S.C. Abeylath, E. Turos, S. Dickey, and D.V. Lim Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis Bioorg. Med. Chem. 16 2008 2412 2418
168. E. Turos, G.S. Reddy, K. Greenhalgh, P. Ramaraju, S.C. Abeylath, S. Jang, S. Dickey, and D.V. Lim Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA Bioorg. Med. Chem. Lett. 17 2007 3468 3472
169. N. Shimizu, K. Otsuka, H. Sawada, T. Maejima, and S. Shirotake Bacteriolysis by vancomycin-conjugated acryl nanoparticles and morphological component analysis Drug Dev. Ind. Pharm. 40 2014 813 818
170. H. Gu, P.L. Ho, E. Tong, L. Wang, and B. Xu Presenting vancomycin on nanoparticles to enhance antimicrobial activities Nano Lett. 55 4 2010 1688 1692
171. M. Alipour, M. Halwani, A. Omri, and Z.E. Suntres Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains Int. J. Pharm. 355 2008 293 298
172. S. Chakraborti, A.K. Mandal, S. Sarwar, P. Singh, R. Chakraborty, and P. Chakrabarti Bactericidal effect of polyethyleneimine capped ZnO nanoparticles on multiple antibiotic resistant bacteria harboring genes of high-pathogenicity island Colloids Surf. B: Biointerfaces 121 2014 44 53
173. S. Tamilvanan, N. Venkateshan, and A. Ludwig The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections J. Control. Release 128 2008 2 22
174. F. Cavalieri, M. Tortora, A. Stringaro, M. Colone, and L. Baldassarri Nanomedicines for antimicrobial interventions J. Hosp. Infect. 88 2014 183 190
175. C.W. Chen, C.Y. Hsu, S.M. Lai, W.J. Syu, T.Y. Wang, and P.S. Lai Metal nanobullets for multidrug resistant bacteria and biofilms Adv. Drug Deliv. Rev. 78 2014 88 104
176. A. Baelo, R. Levato, E. Julian, A. Crespo, J. Astola, J. Gavalda, E. Engel, M.A. Mateos-Timoneda, and E. Torrents Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections J. Control. Release 209 2015 150 158
177. L.M. Sun, C.L. Zhang, and P. Li Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol J. Agric. Food Chem. 60 2012 6150 6156
178. D.R. Monteiro, S. Silva, M. Negri, L.F. Gorup, E.R. de Camargo, R. Oliveira, D.B. Barbosa, and M. Henriques Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms Mycoses 56 2013 672 680
179. W.S. Cheow, M.W. Chang, and K. Hadinoto Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells J. Biomed. Nanotechnol. 6 2010 391 403
180. K. Bastari, M. Arshath, Z.H. Ng, J.H. Chia, Z.X. Yow, B. Sana, M.F. Tan, S. Lim, and S.C. Loo A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm J. Mater. Sci. Mater. Med. 25 2014 747 757
181. H.J. Kim, and M.N. Jones The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes J. Liposome Res. 14 2004 123 139
182. C.J. Seneviratne, K.C. Leung, C.H. Wong, S.F. Lee, X. Li, P.C. Leung, C.B. Lau, E. Wat, and L. Jin Nanoparticle-encapsulated chlorhexidine against oral bacterial biofilms PLoS One 9 2014 e103234
183. R.R. Pillai, S.N. Somayaji, M. Rabinovich, M.C. Hudson, and K.E. Gonsalves Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis Biomed. Mater. 3 2008 034114
184. K.T. Peng, C.F. Chen, I.M. Chu, Y.M. Li, W.H. Hsu, R.W. Hsu, and P.J. Chang Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles Biomaterials 31 2010 5227 5236
185. Y. Cong, C. Quan, M. Liu, J. Liu, G. Huang, G. Tong, Y. Yin, C. Zhang, and Q. Jiang Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin J. Biomater. Sci. Polym. Ed. 26 2015 629 643
186. V. Uskokovic, and T.A. Desai Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. I. Preparation and drug release J. Biomed. Mater. Res. A 101 2013 1416 1426
187. M. Klinger-Strobel, C. Lautenschlager, D. Fischer, J.G. Mainz, T. Bruns, L. Tuchscherr, M.W. Pletz, and O. Makarewicz Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis - where do we stand? Expert Opin. Drug Deliv. 12 2015 1351 1374
188. World Health Organization (WHO) Global Tuberculosis Report 2014 2014 WHO Press
189. A. Dube, Y. Lemmer, R. Hayeshi, M. Balogun, P. Labuschagne, H. Swai, and L. Kalombo State of the art and future directions in nanomedicine for tuberculosis Expert Opin. Drug Deliv. 10 2013 1725 1734
190. Q.T. Zhou, S.S. Leung, P. Tang, T. Parumasivam, Z.H. Loh, and H.K. Chan Inhaled formulations and pulmonary drug delivery systems for respiratory infections Adv. Drug Deliv. Rev. 85 2015 83 99
191. J.C. Sung, D.J. Padilla, L. Garcia-Contreras, J.L. Verberkmoes, D. Durbin, C.A. Peloquin, K.J. Elbert, A.J. Hickey, and D.A. Edwards Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery Pharm. Res. 26 2009 1847 1855
192. A. Kuzmov, and T. Minko Nanotechnology approaches for inhalation treatment of lung diseases J Control Release. 10 2015 500 518
193. S. Chono, K. Kaneko, E. Yamamoto, K. Togami, and K. Morimoto Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages Drug Dev. Ind. Pharm. 36 2010 102 107
194. V. Waters, and F. Ratjen Inhaled liposomal amikacin Expert Rev. Respir. Med. 8 2014 401 409
195. Aradigm Corporation ARD-3150 Pulmaquin® and ARD-3100 Lipoquin® http://www.aradigm.com/products-3100.html.2015 2015
196. D. Lopes, C. Nunes, M.C. Martins, B. Sarmento, and S. Reis Eradication of Helicobacter pylori: past, present and future J. Control. Release 189 2014 169 186
197. S. Harsha Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres Int. J. Nanomedicine 7 2012 4787 4796
198. J. Modi, G. Joshi, and K. Sawant Chitosan based mucoadhesive nanoparticles of ketoconazole for bioavailability enhancement: formulation, optimization, in vitro and ex vivo evaluation Drug Dev. Ind. Pharm. 39 2013 540 547
199. X.L. Zhang, A.M. Jiang, Z.Y. Ma, X.B. Li, Y.Y. Xiong, J.F. Dou, and J.F. Wang The synthetic antimicrobial peptide pexiganan and its nanoparticles (PNPs) exhibit the anti-Helicobacter pylori activity in vitro and in vivo Molecules 20 2015 3972 3985
200. Y.H. Lin, S.C. Tsai, C.H. Lai, C.H. Lee, Z.S. He, and G.C. Tseng Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori Biomaterials 34 2013 4466 4479
201. M. Obonyo, L. Zhang, S. Thamphiwatana, D. Pornpattananangkul, V. Fu, and L. Zhang Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori Mol. Pharm. 9 2012 2677 2685
202. S. Ramteke, N. Ganesh, S. Bhattacharya, and N.K. Jain Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori J. Drug Target. 17 2009 225 234
203. S.Z. Naqvi, U. Kiran, M.I. Ali, A. Jamal, A. Hameed, S. Ahmed, and N. Ali Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria Int. J. Nanomedicine 8 2013 3187 3195
204. M. Doudi, N. Naghsh, and M. Setorki Comparison of the effects of silver nanoparticles on pathogenic bacteria resistant to beta-lactam antibiotics (ESBLs) as a prokaryote model and wistar rats as a eukaryote model Med. Sci. Monit. Basic Res. 19 2013 103 110
205. T. Kruk, K. Szczepanowicz, J. Stefanska, R.P. Socha, and P. Warszynski Synthesis and antimicrobial activity of monodisperse copper nanoparticles Colloids Surf. B: Biointerfaces 128 2015 17 22
206. S. Silva, P. Pires, D.R. Monteiro, M. Negri, L.F. Gorup, E.R. Camargo, D.B. Barbosa, R. Oliveira, D.W. Williams, M. Henriques, and J. Azeredo The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic Med. Mycol. 51 2013 178 184
207. P. Szweda, K. Gucwa, E. Kurzyk, E. Romanowska, K. Dzierzanowska-Fangrat, A. Zielinska Jurek, P.M. Kus, and S. Milewski Essential oils, silver nanoparticles and propolis as alternative agents against fluconazole resistant Candida albicans, Candida glabrata and Candida krusei clinical isolates Indian J. Microbiol. 55 2015 175 183
208. D. Bhattacharya, S. Samanta, A. Mukherjee, C.R. Santra, A.N. Ghosh, S.K. Niyogi, and P. Karmakar Antibacterial activities of polyethylene glycol, tween 80 and sodium dodecyl sulphate coated silver nanoparticles in normal and multi-drug resistant bacteria J. Nanosci. Nanotechnol. 12 2012 2513 2521
209. D. Paredes, C. Ortiz, and R. Torres Synthesis, characterization, and evaluation of antibacterial effect of Ag nanoparticles against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus (MRSA) Int. J. Nanomedicine 9 2014 1717 1729
210. G. Singh, P.K. Babele, S.K. Shahi, R.P. Sinha, M.B. Tyagi, and A. Kumar Green synthesis of silver nanoparticles using cell extracts of anabaena doliolum and screening of its antibacterial and antitumor activity J. Microbiol. Biotechnol. 24 2014 1354 1367
211. M. Eid, and E. Araby Bactericidal effect of poly(acrylamide/itaconic acid)-silver nanoparticles synthesized by gamma irradiation against Pseudomonas aeruginosa Appl. Biochem. Biotechnol. 171 2013 469 487
212. N.K. Palanisamy, N. Ferina, A.N. Amirulhusni, Z. Mohd-Zain, J. Hussaini, L.J. Ping, and R. Durairaj Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa J. Nanobiotechnology 12 2014 2-3155-12-2
213. N.G. Durmus, and T.J. Webster Eradicating antibiotic-resistant biofilms with silver-conjugated superparamagnetic iron oxide nanoparticles Adv. Healthc. Mater. 2 2013 165 171
214. K.D. Leuba, N.G. Durmus, E.N. Taylor, and T.J. Webster Short communication: carboxylate functionalized superparamagnetic iron oxide nanoparticles (SPION) for the reduction of S. aureus growth post biofilm formation Int. J. Nanomedicine 8 2013 731 736
215. G. Subbiahdoss, S. Sharifi, D.W. Grijpma, S. Laurent, H.C. van der Mei, M. Mahmoudi, and H.J. Busscher Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci Acta Biomater. 8 2012 2047 2055
216. M.A. Ansari, H.M. Khan, A.A. Khan, S.S. Cameotra, Q. Saquib, and J. Musarrat Interaction of Al(2)O(3) nanoparticles with Escherichia coli and their cell envelope biomolecules J. Appl. Microbiol. 116 2014 772 783
217. M.K. Rai, S.D. Deshmukh, A.P. Ingle, and A.K. Gade Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria J. Appl. Microbiol. 112 2012 841 852
218. A.T. Saeb, A.S. Alshammari, H. Al-Brahim, and K.A. Al-Rubeaan Production of silver nanoparticles with strong and stable antimicrobial activity against highly pathogenic and multidrug resistant bacteria ScientificWorldJournal 2014 2014 704708
219. M. Rai, S.D. Deshmukh, A.P. Ingle, I.R. Gupta, M. Galdiero, and S. Galdiero Metal nanoparticles: the protective nanoshield against virus infection Crit. Rev. Microbiol. 4 2014 (Epub)
220. D. Xiang, Y. Zheng, W. Duan, X. Li, J. Yin, S. Shigdar, M.L. O'Connor, M. Marappan, X. Zhao, Y. Miao, B. Xiang, and C. Zheng Inhibition of a/human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo Int. J. Nanomedicine 8 2013 4103 4113
221. P.J. Finley, R. Norton, C. Austin, A. Mitchell, S. Zank, and P. Durham Unprecedented silver resistance in clinically isolated enterobacteriaceae: major implications for burn and wound management Antimicrob. Agents Chemother. 59 2015 4734 4741
222. C. Larimer, M.S. Islam, A. Ojha, and I. Nettleship Mutation of environmental mycobacteria to resist silver nanoparticles also confers resistance to a common antibiotic Biometals 27 2014 695 702
223. M. Pollini, F. Paladini, M. Catalano, A. Taurino, A. Licciulli, A. Maffezzoli, and A. Sannino Antibacterial coatings on haemodialysis catheters by photochemical deposition of silver nanoparticles J. Mater. Sci. Mater. Med. 22 2011 2005 2012
224. J. Lellouche, A. Friedman, R. Lahmi, A. Gedanken, and E. Banin Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles Int. J. Nanomedicine 7 2012 1175 1188
225. Y. Evliyaoglu, M. Kobaner, H. Celebi, K. Yelsel, and A. Dogan The efficacy of a novel antibacterial hydroxyapatite nanoparticle-coated indwelling urinary catheter in preventing biofilm formation and catheter-associated urinary tract infection in rabbits Urol. Res. 39 2011 443 449
226. M.O. Gallyamov, I.S. Chaschin, M.A. Khokhlova, T.E. Grigorev, N.P. Bakuleva, I.G. Lyutova, J.E. Kondratenko, G.A. Badun, M.G. Chernysheva, and A.R. Khokhlov Collagen tissue treated with chitosan solutions in carbonic acid for improved biological prosthetic heart valves Mater. Sci. Eng. C. Mater. Biol. Appl. 37 2014 127 140
227. R.P. Allaker The use of nanoparticles to control oral biofilm formation J. Dent. Res. 89 2010 1175 1186
228. J.F. Zhang, R. Wu, Y. Fan, S. Liao, Y. Wang, Z.T. Wen, and X. Xu Antibacterial dental composites with chlorhexidine and mesoporous silica J. Dent. Res. 93 2014 1283 1289
229. M. Agarwala, T. Barman, D. Gogoi, B. Choudhury, A.R. Pal, and R.N. Yadav Highly effective antibiofilm coating of silver-polymer nanocomposite on polymeric medical devices deposited by one step plasma process J. Biomed. Mater. Res. B. Appl. Biomater. 102 2014 1223 1235
230. F. Martinez-Gutierrez, J.M. Guajardo-Pacheco, M.E. Noriega-Trevino, E.P. Thi, N. Reiner, E. Orrantia, Y. Av-Gay, F. Ruiz, and H. Bach Antimicrobial activity, cytotoxicity and inflammatory response of novel plastics embedded with silver nanoparticles Future Microbiol 8 2013 403 411
231. P. Lackner, R. Beer, G. Broessner, R. Helbok, K. Galiano, C. Pleifer, B. Pfausler, C. Brenneis, C. Huck, K. Engelhardt, A.A. Obwegeser, and E. Schmutzhard Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus Neurocrit. Care. 8 2008 360 365
232. J. Lemcke, F. Depner, and U. Meier The impact of silver nanoparticle-coated and antibiotic-impregnated external ventricular drainage catheters on the risk of infections: a clinical comparison of 95 patients Acta Neurochir. Suppl. 114 2012 347 350
233. Z. Cui, B. Wang, Z. Zhong, Y. Sun, Q. Sun, G. Yang, and L. Bian Impact of antibiotic- and silver-impregnated external ventricular drains on the risk of infections: a systematic review and meta-analysis Am. J. Infect. Control 43 2015 e23 e32
234. M. Antonelli, G. De Pascale, V.M. Ranieri, P. Pelaia, R. Tufano, O. Piazza, A. Zangrillo, A. Ferrario, A. De Gaetano, E. Guaglianone, and G. Donelli Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients J. Hosp. Infect. 82 2012 101 107
235. K.N. Stevens, O. Crespo-Biel, E.E. van den Bosch, A.A. Dias, M.L. Knetsch, Y.B. Aldenhoff, F.H. van der Veen, J.G. Maessen, E.E. Stobberingh, and L.H. Koole The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood Biomaterials 30 2009 3682 3690
236. K. Chaloupka, Y. Malam, and A.M. Seifalian Nanosilver as a new generation of nanoproduct in biomedical applications Trends Biotechnol. 28 2010 580 588
237. J.M. Correa, M. Mori, H.L. Sanches, A.D. da Cruz, E. Poiate Jr., and I.A. Poiate Silver nanoparticles in dental biomaterials Int. J. Biomater. 2015 2015 485275
238. H. Cheng, Y. Li, K. Huo, B. Gao, and W. Xiong Long-lasting in vivo and in vitro antibacterial ability of nanostructured titania coating incorporated with silver nanoparticles J. Biomed. Mater. Res. A 102 2014 3488 3499
239. K.D. Secinti, H. Ozalp, A. Attar, and M.F. Sargon Nanoparticle silver ion coatings inhibit biofilm formation on titanium implants J. Clin. Neurosci. 18 2011 391 395
240. H. Qin, H. Cao, Y. Zhao, G. Jin, M. Cheng, J. Wang, Y. Jiang, Z. An, X. Zhang, and X. Liu Antimicrobial and osteogenic properties of silver-ion-implanted stainless steel ACS Appl. Mater. Interfaces 7 2015 10785 10794
241. E. Elizabeth, G. Baranwal, A.G. Krishnan, D. Menon, and M. Nair ZnO nanoparticle incorporated nanostructured metallic titanium for increased mesenchymal stem cell response and antibacterial activity Nanotechnology 25 2014 115101
242. K. Memarzadeh, A.S. Sharili, J. Huang, S.C. Rawlinson, and R.P. Allaker Nanoparticulate zinc oxide as a coating material for orthopedic and dental implants J. Biomed. Mater. Res. A 103 2015 981 989
243. L. Pichavant, G. Amador, C. Jacqueline, B. Brouillaud, V. Heroguez, and M.C. Durrieu pH-controlled delivery of gentamicin sulfate from orthopedic devices preventing nosocomial infections J. Control. Release 162 2012 373 381
244. M. Arora, E.K. Chan, S. Gupta, and A.D. Diwan Polymethylmethacrylate bone cements and additives: a review of the literature World J. Orthop. 4 2013 67 74
245. Z. Shi, K.G. Neoh, E.T. Kang, and W. Wang Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles Biomaterials 27 2006 2440 2449
246. S.C. Shen, W.K. Ng, Z. Shi, L. Chia, K.G. Neoh, and R.B. Tan Mesoporous silica nanoparticle-functionalized poly(methyl methacrylate)-based bone cement for effective antibiotics delivery J. Mater. Sci. Mater. Med. 22 2011 2283 2292
247. P. Prokopovich, R. Leech, C.J. Carmalt, I.P. Parkin, and S. Perni A novel bone cement impregnated with silver-tiopronin nanoparticles: its antimicrobial, cytotoxic, and mechanical properties Int. J. Nanomedicine 8 2013 2227 2237
248. C.E. Albers, W. Hofstetter, K.A. Siebenrock, R. Landmann, and F.M. Klenke In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations Nanotoxicology 7 2013 30 36
249. A. Hebeish, M.H. El-Rafie, M.A. El-Sheikh, A.A. Seleem, and M.E. El-Naggar Antimicrobial wound dressing and anti-inflammatory efficacy of silver nanoparticles Int. J. Biol. Macromol. 65 2014 509 515
250. J.T. van Dissel, S.A. Joosten, S.T. Hoff, D. Soonawala, C. Prins, D.A. Hokey, D.M. O'Dee, A. Graves, B. Thierry-Carstensen, L.V. Andreasen, M. Ruhwald, A.W. de Visser, E.M. Agger, T.H. Ottenhoff, I. Kromann, and P. Andersen A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human Vaccine 32 2014 7098 7107
251. U.S. National Institutes of Health, ClinicalTrials.gov,2015 (2015).
252. L.H. Lua, N.K. Connors, F. Sainsbury, Y.P. Chuan, N. Wibowo, and A.P. Middelberg Bioengineering virus-like particles as vaccines Biotechnol. Bioeng. 111 2014 425 440
253. V. Giacomet, F. Penagini, D. Trabattoni, A. Vigano, V. Rainone, G. Bernazzani, C.M. Bonardi, M. Clerici, G. Bedogni, and G.V. Zuccotti Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults Vaccine 32 2014 5657 5661
254. B. Rodriguez, D.M. Asmuth, R.M. Matining, J. Spritzler, J.M. Jacobson, R.B. Mailliard, X.D. Li, A.I. Martinez, A.R. Tenorio, F. Lori, J. Lisziewicz, S. Yesmin, C.R. Rinaldo, and R.B. Pollard Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial J. Acquir. Immune Defic. Syndr. 64 2013 351 359
255. S. Owusu-Agyei, D. Ansong, K. Asante, S.K. Owusu, R. Owusu, N.A.W. Brobby, D. Dosoo, A.O. Akoto, K. Osei-Kwakye, E.A. Adjei, K.O. Boahen, J. Sylverken, G. Adjei, D. Sambian, S. Apanga, K. Kayan, J. Vekemans, O. Ofori-Anyinam, A. Leach, M. Lievens, M.A. Demoitie, M.C. Dubois, J. Cohen, W.R. Ballou, B. Savarese, D. Chandramohan, J.O. Gyapong, P. Milligan, S. Antwi, T. Agbenyega, B. Greenwood, and J. Evans Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children PLoS One 4 2009 e7302
256. D. Ansong, K.P. Asante, J. Vekemans, S.K. Owusu, R. Owusu, N.A. Brobby, D. Dosoo, A. Osei-Akoto, K. Osei-Kwakye, E. Asafo-Adjei, K.O. Boahen, J. Sylverken, G. Adjei, D. Sambian, S. Apanga, K. Kayan, M.H. Janssens, M.J. Lievens, A.C. Olivier, E. Jongert, P. Dubois, B.M. Savarese, J. Cohen, S. Antwi, B.M. Greenwood, J.A. Evans, T. Agbenyega, P.J. Moris, and S. Owusu-Agyei T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children PLoS One 6 2011 e18891
257. S.T. Agnandji, R. Fendel, M. Mestre, M. Janssens, J. Vekemans, J. Held, F. Gnansounou, S. Haertle, I. von Glasenapp, S. Oyakhirome, L. Mewono, P. Moris, M. Lievens, M.A. Demoitie, P.M. Dubois, T. Villafana, E. Jongert, A. Olivier, J. Cohen, M. Esen, P.G. Kremsner, B. Lell, and B. Mordmuller Induction of Plasmodium falciparum-specific CD4 + T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D) PLoS One 6 2011 e18559
258. S.C.T.P. RTS Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial Lancet 386 2015 31 45
259. P. Burkhard, and D.E. Lanar Malaria vaccine based on self-assembling protein nanoparticles Expert Rev. Vaccines 14 2015 1525 1527
260. D. Pawar, and K.S. Jaganathan Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response Drug Deliv. 1-11 2014
261. C.J. Davitt, and E.C. Lavelle Delivery strategies to enhance oral vaccination against enteric infections Adv. Drug Deliv. Rev. 8 2015 52 69
262. S. Jain, H. Harde, A. Indulkar, and A.K. Agrawal Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration Nanomedicine 10 2014 431 440
263. C. Sawaengsak, Y. Mori, K. Yamanishi, A. Mitrevej, and N. Sinchaipanid Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine AAPS PharmSciTech 15 2014 317 325
264. W. Tao, K.S. Ziemer, and H.S. Gill Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus Nanomedicine (London) 9 2014 237 251
265. L. Pan, Z. Zhang, J. Lv, P. Zhou, W. Hu, Y. Fang, H. Chen, X. Liu, J. Shao, F. Zhao, Y. Ding, T. Lin, H. Chang, J. Zhang, Y. Zhang, and Y. Wang Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles Int. J. Nanomedicine 9 2014 5603 5618
266. M.S. Muthu, D.T. Leong, L. Mei, and S.S. Feng Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics Theranostics 4 2014 660 677
267. F. Chen, E.B. Ehlerding, and W. Cai Theranostic nanoparticles J. Nucl. Med. 55 2014 1919 1922
268. T. Yoshitomi, R. Suzuki, T. Mamiya, H. Matsui, A. Hirayama, and Y. Nagasaki pH-sensitive radical-containing-nanoparticle (RNP) for the L-band-EPR imaging of low pH circumstances Bioconjug. Chem. 20 2009 1792 1798
269. M.E. El Zowalaty, S.H.H.A. Ali, M.I. Husseiny, B.M. Geilich, T.J. Webster, and M.Z. Hussein The ability of streptomycin-loaded chitosan-coated magnetic nanocomposites to possess antimicrobial and antituberculosis activities Int. J. Nanomedicine 10 2015 3269 3274
270. S.G. Beal, J. Ciurca, G. Smith, J. John, F. Lee, C.D. Doern, and R.M. Gander Evaluation of the nanosphere verigene Gram-positive blood culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients J. Clin. Microbiol. 51 2013 3988 3992
271. C.M. Wojewoda, L. Sercia, M. Navas, M. Tuohy, D. Wilson, G.S. Hall, G.W. Procop, and S.S. Richter Evaluation of the Verigene Gram-positive blood culture nucleic acid test for rapid detection of bacteria and resistance determinants J. Clin. Microbiol. 51 2013 2072 2076
272. Q. Chen, L. Yuan, J. Wan, Y. Chen, and C. Du Colorimetric detection of hepatitis E virus based on reverse transcription loop mediated isothermal amplification (RT-LAMP) assay J. Virol. Methods 197 2014 29 33
273. F. Inci, O. Tokel, S. Wang, U.A. Gurkan, S. Tasoglu, D.R. Kuritzkes, and U. Demirci Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood ACS Nano 7 2013 4733 4745
274. 4) nanoparticles for capturing Gram-positive and Gram-negative bacteria J. Biomed. Nanotechnol. 10 2014 1429 1439
275. E.Y. Lukianova-Hleb, and D.O. Lapotko Malaria theranostics using hemozoin-generated vapor nanobubbles Theranostics 4 2014 761 769
276. H.I. Chang, and M.K. Yeh Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy Int. J. Nanomedicine 7 2012 49 60
277. V. Weissig, T.K. Pettinger, and N. Murdock Nanopharmaceuticals (part 1): products on the market Int. J. Nanomedicine 9 2014 4357 4373
278. P.D. Marcato, and N. Duran New aspects of nanopharmaceutical delivery systems J. Nanosci. Nanotechnol. 8 2008 2216 2229
279. K. Bruynesteyn, V. Gant, C. McKenzie, T. Pagliuca, C. Poynton, R.N. Kumar, and J.P. Jansen A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK Eur. J. Haematol. 78 2007 532 539
280. D. Al-Badriyeh, D. Liew, K. Stewart, and D.C. Kong Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia J. Antimicrob. Chemother. 63 2009 1276 1285
281. S. Naik, J. Lundberg, R. Kumar, J. Sjolin, and J.P. Jansen Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden Scand. J. Infect. Dis. 43 2011 504 514
282. R. Bosetti, W. Marneffe, and L. Vereeck Assessing the need for quality-adjusted cost-effectiveness studies of nanotechnological cancer therapies Nanomedicine (London) 8 2013 487 497